- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
SMS Hospital gives Anti-HIV drugs to coronavirus-affected elderly Italian couple
The Drug Controller General of India has approved "restricted use" of the combination of medications lopinavir and ritonavir which are second-line HIV drugs, for treating those affected by novel coronavirus after the Indian Council of Medical Research (ICMR) sought an emergency approval for the same.
New Delhi- Amid rising coronavirus cases in India, for the first time a combination of two drugs, which is widely used for controlling HIV infection, was administered on an elderly Italian couple undergoing treatment at a Jaipur hospital for Covid-19.
The Drug Controller General of India has approved "restricted use" of the combination of medications lopinavir and ritonavir which are second-line HIV drugs, for treating those affected by novel coronavirus after the Indian Council of Medical Research (ICMR) sought an emergency approval for the same.
Read Also:Drinking Adversely Affects Bone Health Of People Living With HIV: Study
SMS Hospital Medical Superintendent Dr D S Meena said the Italian man and his wife had developed severe respiratory problems following which a decision was taken to put them on the combination of lopinavir and ritonavir.
According to officials, consent of the patients was taken before the drugs were administered.
"The Italian man, who himself is a doctor, is on oxygen support. Even before he acquired the infection, he had some respiratory issues. His condition had deteriorated and he developed severe respiratory problems after getting the coronavirus infection and thus was given these drugs.
"His condition is stable now. His wife is also doing better and she is taking care of her husband," Dr Meena said.
The combination of lopinavir and ritonavir along with other drugs have been used in clinical trials in China, where coronavirus first emerged, and Thailand for treating Covid-19 patients.
The couple were among the 16 Italian tourists who and their Indian guide tested positive for coronavirus. Except the couple, 14 Italian tourists are currently admitted at Medanta hospital while the Indian guide is being treated at Safdarjung Hospital in Delhi.
According to health ministry officials, the number of confirmed coronavirus cases in the country stood at 44. However, the ICMR has also counted three persons from Karnataka and two from Pune as positive, which once taken into account takes the total 49.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751